Cover image of the article: Hypnoanalgesia: A Bridge Between Neuroscience and Clinical Settings

Image Credit:Interv Pain Med Neuromod

Hypnoanalgesia: A Bridge Between Neuroscience and Clinical Settings

Authors

Danial NejadmasoomDanial Nejadmasoom ORCID1, 2,*
1Department of Language and Literature, Islamic Azad University of Chalus, Chalus, Iran
2Universal Scientific Education and Research Network, Tehran, Iran
*Corresponding Author: Department of Language and Literature, Islamic Azad University of Chalus, Chalus, Iran. Email: danialnej@iauc.ac.ir

Interventional Pain Medicine and Neuromodulation:Vol. 2, issue 1; e127650
Published online:May 31, 2022
Article type:Letter
Received:May 09, 2022
Accepted:May 17, 2022
How to Cite:Nejadmasoom D. Hypnoanalgesia: A Bridge Between Neuroscience and Clinical Settings. Interv Pain Med Neuromod. 2022;2(1):e127650. doi: https://doi.org/10.5812/ipmn-127650

Dear Editor,
Historically, hypnosis has been widely applied for clinical purposes. For instance, we can mention Anton Mesmer (1734 - 1815) as the father of modern hypnosis that used this technique for treatment. However, the first well-known reports on the application of hypnosis in surgery and analgesia (hypnoanalgesia) are related to James Esdaile (1808 - 1859) in India (1). Some promising results showed the brain capability to reduce pain. In this way, some neuroscientists considered hypnosis as subject of their studies. Santiago Ramón y Cajal (1852 - 1934), Nobel Prize laureate, is famous for his discovery on mechanism of neuronal morphology and connections. He published one of the first case studies on using hypnoanalgesia for childbirth (1). Cajal showed that hypnosis works, but he could not describe how hypnosis could change brain to reduce pain.
Considering the advancement in neuroimaging research in previous decades, we know that there is not a ‘pain center’ in the brain; in fact, pain experience is a product of complex interaction between certain brain areas (neuro matrix) and peripheral nervous system (2). Anterior cingulate cortex (ACC), insular cortex, thalamus, prefrontal cortex (PFC), primary and secondary sensory cortices are some cortical areas that most often contributes to pain experience (2). A body of neuroimaging studies indicated that hypnosis could modulate all these brain areas, and even some evidence suggested that hypnosis could have an influence on spinal mechanisms of aversive stimulation processing (2).
Neuroimaging studies give objective information that suggests hypnosis is not a simple imagination. An fMRI study by Derbyshire et al. (cited in Jensen and Patterson) compared three painful conditions with each other as follows: (1) pain induced by noxious stimulation, (2) imagination about pain, and (3) hypnotic-induced pain. Brain patterns in first (noxious stimulation) and third (hypnotic pain) conditions were similar. This means that the fMRI results showed an overlap between some areas such as ACC, PFC, thalamus, insula, and some other areas involved in pain experience. Although the intensity of these brain activities in first condition was higher than hypnotic pain, hypnosis group had greater brain activity than imagination group (2).
Besides the great impact of neuroscience on our understanding of what hypnosis really is and how it works, recent studies showed the effectiveness of hypnoalgesia in clinical setting. A meta-analysis on 85 experimental studies indicated that hypnoanalgesia reduced pain up to 42% (3). In addition, hypnosis can go beyond the pain reduction. Another meta-analysis on breast cancer patients undergoing minor surgery showed that along with the significant postoperative pain reduction, there were lower levels of preoperative anxiety in the patients (4).
One of the advantages of hypnosis, as a therapeutic tool is that clinicians can add it to other interventions for grater effectiveness. For example, in a study on fibromyalgia patients, researchers added hypnosis to multicomponent cognitive-behavioral therapy (CBT) and compared this group with two pharmacological treatment (standard care) and multicomponent CBT groups. After six-month follow-up, the results showed that some symptoms such as pain intensity, catastrophizing, and psychological distress significantly improved in the first group (multicomponent CBT+ hypnosis) compared to two other groups (5).
We can also consider the cost-effectiveness of this intervention. In 2007, a study on 200 breast cancer patients by Montgomery et al. (cited in Jensen and Patterson) reported that patients in the hypnosis group needed less drugs like propofol and lidocaine for sedation and analgesia. In addition, they reported less pain and reduced symptoms like nausea and fatigue. Moreover, regarding costs, an average of $772.71 was saved per patient (2).
Hypnoanalgesia is a bridge between neuroscience research, looking for neural mechanisms underlying hypnosis, and studies suggesting the effectiveness of hypnosis in clinical settings. Further research can develop the application of hypnosis.

Footnotes

  • Authors' Contribution: DN drafted the manuscript, revised the manuscript, and approved the final version for publication.

  • Conflict of Interests: The author declares that there are no conflicts of interest.

  • Funding/Support: The author received no financial support for the research, authorship, and/or publication of this article.

References

  • 1.
    Lanfranco RC, Canales-Johnson A, Huepe D. Hypnoanalgesia and the study of pain experience: from Cajal to modern neuroscience. Front Psychol. 2014;5:1126. [PubMed ID: 25324822]. [PubMed Central ID: PMC4179709]. https://doi.org/10.3389/fpsyg.2014.01126.
  • 2.
    Jensen MP, Patterson DR. Hypnotic approaches for chronic pain management: clinical implications of recent research findings. Am Psychol. 2014;69(2):167-77. [PubMed ID: 24547802]. [PubMed Central ID: PMC4465776]. https://doi.org/10.1037/a0035644.
  • 3.
    Thompson T, Terhune DB, Oram C, Sharangparni J, Rouf R, Solmi M, et al. The effectiveness of hypnosis for pain relief: A systematic review and meta-analysis of 85 controlled experimental trials. Neurosci Biobehav Rev. 2019;99:298-310. [PubMed ID: 30790634]. https://doi.org/10.1016/j.neubiorev.2019.02.013.
  • 4.
    Zeng J, Wang L, Cai Q, Wu J, Zhou C. Effect of hypnosis before general anesthesia on postoperative outcomes in patients undergoing minor surgery for breast cancer: a systematic review and meta-analysis. Gland Surg. 2022;11(3):588-98. [PubMed ID: 35402208]. [PubMed Central ID: PMC8984985]. https://doi.org/10.21037/gs-22-114.
  • 5.
    Castel A, Cascon R, Padrol A, Sala J, Rull M. Multicomponent cognitive-behavioral group therapy with hypnosis for the treatment of fibromyalgia: long-term outcome. J Pain. 2012;13(3):255-65. [PubMed ID: 22285609]. https://doi.org/10.1016/j.jpain.2011.11.005.

Copyright

Copyright © 2022, Interventional Pain Medicine and Neuromodulation. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.

Similar Articles

29
Jan
2017
Hypnoanalgesia for Dilatation and Curettage Pain Control

Hypnoanalgesia for Dilatation and Curettage Pain Control

Mehdi Fathi,
Susan Aziz Mohammadi,
Mehdi Moslemifar,
Kurosh Kamali,
Marjan Joudi,
Azam Sabri Benhangi
,et al.

Fathi M, Aziz Mohammadi S, Moslemifar M, Kamali K, Joudi M, et al. Hypnoanalgesia for Dilatation and Curettage Pain Control. Anesth Pain Med. 2017;7(2):e44628. doi: https://doi.org/10.5812/aapm.44628

12
May
2017
Sleep and anesthesia: can we use a physiologic model to decrease risks of a medical intervention

Sleep and anesthesia: can we use a physiologic model to decrease risks of a medical intervention

Ali Dabbagh,
Samira Rajaei

Dabbagh A, Rajaei S. Sleep and anesthesia: can we use a physiologic model to decrease risks of a medical intervention. J Cell Mol Anesth. 2017;2(2):e149720. doi: https://doi.org/10.22037/jcma.v2i2.11689

18
Oct
2026
Natural Products in Opioid-Related Pain and Neurobehavioral Outcomes: Translational Perspectives for Anesthesiology and Perioperative Medicine (AI-generated illustration)

Natural Products in Opioid-Related Pain and Neurobehavioral Outcomes: Translational Perspectives for Anesthesiology and Perioperative Medicine

Eskandar Moghimipour,
Masood Fereidoonnezhad

Moghimipour E, Fereidoonnezhad M. Natural Products in Opioid-Related Pain and Neurobehavioral Outcomes: Translational Perspectives for Anesthesiology and Perioperative Medicine. J Cell Mol Anesth. 2026;11(3):e175859. doi: https://doi.org/10.5812/jcma-175859

30
Mar
2015
Neuraxial Dexmedetomidine: Wonder Drug or Simply Harmful

Neuraxial Dexmedetomidine: Wonder Drug or Simply Harmful

Sohan Lal Solanki,
Vipin Kumar Goyal

Solanki SL, Goyal VK. Neuraxial Dexmedetomidine: Wonder Drug or Simply Harmful. Anesth Pain Med. 2015;5(2):e22651. doi: https://doi.org/10.5812/aapm.22651

17
Aug
2019
Hypnosis as an Approach to Control Pain and Anxiety in Anterior Cruciate Ligament Reconstruction and Meniscal Surgeries: Two Case Presentations

Hypnosis as an Approach to Control Pain and Anxiety in Anterior Cruciate Ligament Reconstruction and Meniscal Surgeries: Two Case Presentations

Mehdi Fathi,
Amir Shahriar Ariamanesh,
Marjan Joudi,
Mitra Joudi,
Farhood Sadrossadati,
Azra Izanloo

Fathi M, Ariamanesh AS, Joudi M, Joudi M, Sadrossadati F, et al. Hypnosis as an Approach to Control Pain and Anxiety in Anterior Cruciate Ligament Reconstruction and Meniscal Surgeries: Two Case Presentations. Anesth Pain Med. 2019;9(4):e89277. doi: https://doi.org/10.5812/aapm.89277

More by these authors

Danial NejadmasoomPubMedScholar
Share
Cited by
Metrics